Hidetoshi Igari
Impact in
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- Tuberculosis Research and Epidemiology
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
-
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Neonatal Respiratory Health Research
Papers in
-
- Tuberculosis Research and Epidemiology 15
- SARS-CoV-2 and COVID-19 Research 10
- COVID-19 Clinical Research Studies 7
- Epidemiology 25
- Mycobacterium research and diagnosis 10
- Pneumocystis jirovecii pneumonia detection and treatment 6
- Influenza Virus Research Studies 5
- Pneumonia and Respiratory Infections 4
- Co-authors
- Takayuki Kuriyama (8 shared papers)Koichiro Tatsumi (10 shared papers)Seiichiro Sakao (9 shared papers)Yuji Shino (3 shared papers)Hiroshi Shirasawa (3 shared papers)Toshibumi Taniguchi (26 shared papers)Shota Murata (11 shared papers)Kazuyuki Matsushita (7 shared papers)
- Journals
- The International Journal of Tuberculosis and Lung Disease (3 papers)Clinica Chimica Acta (3 papers)CHEST Journal (2 papers)Journal of Infection and Chemotherapy (16 papers)International Journal of Infectious Diseases (1 paper)
- Partner nations
- JapanUnited States
In The Last Decade
Hidetoshi Igari
59 papers receiving 887 citations
Peers
Comparison fields: 5 of 90
- Infectious Diseases 391
- Pulmonary and Respiratory Medicine 195
- Virology 29
- Emergency Medical Services 38
- Epidemiology 166
Countries citing papers authored by Hidetoshi Igari
This map shows the geographic impact of Hidetoshi Igari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hidetoshi Igari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hidetoshi Igari more than expected).
Fields of papers citing papers by Hidetoshi Igari
This network shows the impact of papers produced by Hidetoshi Igari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hidetoshi Igari. The network helps show where Hidetoshi Igari may publish in the future.
Co-authors
The 25 scholars most cited alongside Hidetoshi Igari, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 134 | |
| 2 | 2021 | 94 | |
| 3 | 2020 | 73 | |
| 4 | 2002 | 62 | |
| 5 | 2006 | 45 | |
| 6 | 2020 | 42 | |
| 7 | Booster phenomenon of QuantiFERON-TB Gold after prior intradermal PPD injection. | 2007 | 35 |
| 8 | 2003 | 35 | |
| 9 | 2017 | 32 | |
| 10 | 2012 | 28 | |
| 11 | 2016 | 25 | |
| 12 | 2009 | 24 | |
| 13 | 2017 | 19 | |
| 14 | 2020 | 19 | |
| 15 | 2015 | 18 | |
| 16 | 2024 | 16 | |
| 17 | 2010 | 14 | |
| 18 | 1998 | 14 | |
| 19 | 2011 | 13 | |
| 20 | 2017 | 12 |
About Hidetoshi Igari
Hidetoshi Igari is a scholar working on Infectious Diseases, Epidemiology, Surgery, Immunology and Pulmonary and Respiratory Medicine, having authored 64 papers that have together received 909 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (15 papers), Mycobacterium research and diagnosis (10 papers), SARS-CoV-2 and COVID-19 Research (10 papers), COVID-19 Clinical Research Studies (7 papers), Pneumocystis jirovecii pneumonia detection and treatment (6 papers), Influenza Virus Research Studies (5 papers), Diagnosis and treatment of tuberculosis (5 papers) and Pneumonia and Respiratory Infections (4 papers). The work is most often cited by research in Infectious Diseases (391 citations), Pulmonary and Respiratory Medicine (195 citations), Virology (29 citations), Emergency Medical Services (38 citations) and Epidemiology (166 citations). Hidetoshi Igari has collaborated with scholars based in Japan and United States. Frequent co-authors include Takayuki Kuriyama, Koichiro Tatsumi, Seiichiro Sakao, Yuji Shino, Hiroshi Shirasawa, Toshibumi Taniguchi, Shota Murata, Kazuyuki Matsushita, Taka‐aki Nakada and Andréia Watanabe. Their work appears in journals such as The International Journal of Tuberculosis and Lung Disease, Clinica Chimica Acta, CHEST Journal, Journal of Infection and Chemotherapy and International Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.